Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs

Journal of Molecular Biology

Volumn 257, Issue 2, 1996, Pages 246-264

  Mikaélian, Ivan ^a   Krieg, Marion ^a   Gait, Michael J ^a   Karn, Jonathan ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

INS (CRS) elements; Rev; Rev response element (RRE); RNA binding proteins; RNA splicing

Indexed keywords

BETA GLOBIN; GAG PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA; MESSENGER RNA PRECURSOR; NUCLEAR FACTOR; POL PROTEIN; REV PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR INTERACTION; MOLECULAR STABILITY; MUTATION; NONHUMAN; PRIORITY JOURNAL; RNA SPLICING; STRUCTURAL GENE;

EID: 0040282093     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0160     Document Type: Article

References (82)

1. Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey R., Rabson, A. & Martin, M. A. (1986). Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59, 284-291.
2. Amendt, B. A., Hesslein, D., Chang, L.-J. & Stoltzfus, C. M. (1994). Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1. Mol. Cell Biol. 14, 3960-3970.
3. Amendt, B. A., Si, Z.-H. & Stoltzfus, C. M. (1995). Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors. Mol. Cell Biol. 15, 4606-4615.
4. Arrigo, S. J., Wietsman, S., Zack, J. A. & Chen, I. S. Y. (1990). Characterization and expression of novel singly spliced RNA species of human immunodeficiency virus type 1. J. Virol. 64, 4585-4588.
5. Barksdale, S. K. & Baker, C. C. (1995). The human immunodeficiency virus type 1 Rev protein and the Rev-response element counteract the effect of an inhibitory 5′ splice site in a 3′ untranslated region. Mol. Cell Biol. 15, 2962-2971.
6. Bartel, D. P., Zapp, M. L., Green, M. R. & Szostak, J. W. (1991). HIV-1 Rev regulation involves recognition of non-Watson-Crick base-pairs in viral RNA. Cell, 67, 529-536.
7. Black, A. C., Luo, J., Watanabe, C., Chun, S., Bakker, A., Fraser, J. K., Morgan, J. P. & Rosenblatt, J. D. (1995). Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements. J. Virol. 69, 6852-6858.
8. Bogerd, H. P., Fridell, R. A., Madore, S. & Cullen, B. R. (1995). Identification of a novel cellular co-factor for the Rev/Rex class of retroviral regulatory proteins. Cell, 82, 485-494.
9. Bray, M., Prasad, S., Dubay J. W., Hunter, E., Jeang, K.-T., Rekosh, D. & Hammarskjöld, M.-L. (1994). A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc. Natl Acad. Sci. USA, 91, 1256-1260.
10. Brighty, D. W. & Rosenberg, M. (1994). A cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals. Proc. Natl Acad. Sci. USA, 91, 8314-8318.
11. Buchman, A. R. & Berg, P. (1988). Comparison of intron-dependent and intron-independent gene expression. Mol. Cell Biol. 8, 4395-4405.
12. Chang, D. A. & Sharp, P. A. (1989). Regulation by HIV Rev depends upon recognition of splice site. Cell, 59, 789-795.
13. Chen, C.-Y. A., You, Y. & Shyu, A.-B. (1992). Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability Mol. Cell Biol. 12, 5748-5757.
14. Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Anal. Biochem. 162, 156-159.
15. Cochrane, A. W., Chen, C.-H. & Rosen, C. A. (1990a). Specific interaction of the human immuodeficiency virus Rev protein with a structured region in the env mRNA. Proc. Natl Acad. Sci. USA, 87, 1198-1202.
16. Cochrane, A. W., Perkins, A. & Rosen, C. A. (1990b). Identification of sequences important in the nucleolar localization of human immunodeficiency virus Rev: relevance of nucleolar localization to function. J. Virol. 64, 881-885.
17. Cochrane, A. W., Jones, K. S., Beidas, S., Dillon, P. J., Skalka, A. M. & Rosen, C. A. (1991). Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J. Virol. 65, 5305-5313.
18. Daly, T. J., Cook, K. S., Gary, G. S., Maione, T. E. & Rusche, J. R. (1989). Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature, 342, 816-819.
19. Dayton, E. T., Powell, D. M. & Dayton, A. I. (1989). Functional analysis of CAR, the target sequence for the Rev protein of HIV-1. Science, 246, 1625-1629.
20. Dreyfuss, G., Matunis, M. J., Piñol-Roma, S. & Burd, C. G. (1993). hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem. 62, 289-321.
21. Emerman, M., Vazeaux, R. & Peden, K. (1989). The rev gene product of the human immunodeficiency virus affects envelope specific RNA localization. Cell, 57, 1155-1165.
22. Feinberg, M. B., Jarrett, R. F., Aldovini, A., Gallo, R. C. & Wong-Staal, F. (1986). HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell, 46, 807-817.
23. Felber, B. K., Hadzopoulou-Cladaras, M., Cladaras, C., Copeland, T. & Pavlakis, G. N. (1989). Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc. Natl Acad. Sci. USA, 86, 1495-1499.
24. Fischer, U., Meyer, S., Teufel, M., Heckel, C., Lührmann, R. & Rautmann, G. (1994). Evidence that HIV-1 Rev directly promotes the nuclear export of unspliced RNA. EMBO J. 13, 4105-4112.
25. Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W. & Lührmann, R. (1995). The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell, 82, 475-483.
26. Fritz, C. C., Zapp, M. L. & Green, M. R. (1995). A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature, 376, 530-533.
27. Gorman, C. M., Padmanabliam, R. & Howard, B. H. (1983). High efficiency DNA-mediated transformation of primate cells. Science, 221, 551-553.
28. Hadzopoulou-Cladaras, M., Felber, B. K., Cladaras, C., Athanassopoulos, A., Tse, A. & Pavlakis, G. N. (1989). The Rev/Art protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63, 1265-1274.
29. Hammarskjöld, M.-L., Heimer, J., Hammarskjöld, B., Sangwan, I., Albert, L. & Rekosh, D. (1989). Regulation of human immunodeficiency virus env gene expression by the rev gene product. J. Virol. 63, 1959-1966.
30. Hammarskjöld, M.-L., Li, H., Rekosh, D. & Prasad, S. (1994). Human immunodeficiency virus env expression becomes rev-independent if the env region is not defined as an intron. J. Virol. 68, 951-958.
31. Heaphy S., Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Karn, J., Lowe, A. D., Singh, M. & Skinner, M. A. (1990). HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev-response element region. Cell, 60, 685-693.
32. Heaphy, S., Finch, J. T., Gait, M. J., Karn, J. & Singh, M. (1991). Human imunodeficiency virus type 1 regulator of virion expression, Rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral RNA. Proc. Natl Acad. Sci. USA, 88, 7366-7370.
33. Huang, X., Hope, T. J., Bond, B. L., McDonald, D., Grahl, K. & Parslow, T. G. (1991). Minimal Rev-response element for type 1 human immuodeficiency virus. J. Virol. 65, 2131-2134.
34. Iwai, S., Pritchard, C., Mann, D. A., Karn, J. & Gait, M. J. (1992). Recognition of the high affinity binding site in Rev-response element RNA by the human immunodeficiency virus type-1 Rev protein. Nucl. Acids Res. 20, 6465-6472.
35. Kalland, K.-H., Szilvay A. M., Brokstad, K. A., Sætrevik, W. & Haukenes, G. (1994). The human immunodeficiency virus type-1 Rev protein shuttles between the cytoplasm and nuclear compartments. Mol. Cell Biol. 14, 7436-7444.
36. Katz, R. A., Kotler, M. & Skalka, A. M. (1988). Cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implication for mechanisms of control. J. Virol. 62, 2686-2695.
37. Kjems, J. & Sharp, P. A. (1993). The basic domain of rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6-U5 small nuclear ribonucleoprotein in spliceosome assembly. J. Virol. 67, 4769-4776.
38. Kjems, J., Frankel, A. D. & Sharp, P. A. (1991). Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. Cell, 67, 169-178.
39. Kjems, J., Calnan, B. J., Frankel, A. D. & Sharp, P. A. (1992). Specific binding of a basic peptide from HIV-1 Rev. EMBO J. 11, 1119-1129.
40. Liu, X. & Mertz, J. E. (1995). HnRNP L binds a cis-acting RNA sequence element that enables intron-independent gene expression. Genes Dev. 9, 1766-1780.
41. Lu, X., Heimer, J., Rekosh, D. & Hammarskjöld, M.-L. (1990). U1 small nuclear RNA plays a direct role in the formation of a Rev-regulated human immunodeficiency virus env mRNA that remains unspliced. Proc. Natl Acad. Sci. USA, 87, 7598-7602.
42. Maldarelli, F., Martin, M. A. & Strebel, K. (1991). Identification of posttranscriptionally active inhibitor sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65, 5732-5743.
43. Malim, M. H. & Cullen, B. R. (1991). HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency Cell, 65, 241-248.
44. Malim, M. H. & Cullen, B. R. (1993). Rev and the fate of pre-mRNA in the nucleus: Implications for the regulation of RNA processing in eukaryotes. Mol. Cell Biol. 13, 6180-6189.
45. Malim, M. H., Bohnlein, S., Hauber, J. & Cullen, B. R. (1989a). Functional dissection of the the HIV-1 Rev trans-activator: derivation of a trans-dominant repressor of Rev function. Cell, 58, 205-214.
46. Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V. & Cullen, B. R. (1989b). The HIV-1 Rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature, 338, 254-257.
47. Malim, M. H., Tiley L. S., McCarn, D. F., Rusche, J. R., Hauber, J. & Cullen, B. R. (1990). HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell, 60, 675-683.
48. Malim, M. H., McCarn, D. F., Tiley, L. S. & Cullen, B. R. (1991). Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65, 4248-4254.
49. Manet, E., Allera, C., Gruffat, H., Mikaélian, I., Rigolet, A. & Sargeant, A. (1993). The acidic activation domain of the Epstein-Barr virus transcription factor R interacts in vitro with both TBP and TFIIB and is cell-specifically potentiated by a proline-rich region. Gene Expression, 3, 49-59.
50. Mann, D. A., Mikaélian, I., Zemmel, R. W., Green, S. M., Lowe, A. D., Kimura, T., Singh, M., Butler, P. J. G., Gait, M. J. & Karn, J. (1994). A molecular rheostat: co-operative Rev binding to stem I of the Rev-response element modulates human immunodeficiency virus type-1 late gene expression. J. Mol. Biol. 241, 193-207.
51. McNally M. T. & Beemon, K. (1992). Intronic sequences and 3′ splice sites control Rous sarcoma virus RNA splicing. J. Virol. 66, 6-11.
52. McNally M. T., Gontarek, R. R. & Beemon, K. (1991). Characterization of Rous sarcoma virus intronic sequences that negatively regulate splicing. Virology, 185, 99-108.
53. Meyer, B. E. & Malim, M. H. (1994). The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 8, 1538-1547.
54. Mikaélian, I. & Sergeant, A. (1992). A general and fast method to generate multiple site directed mutations. Nucl. Acids Res. 20, 376.
55. Nasioulas, G., Zolotukhin, A. S., Tabernero, C., Solomin, L., Cunningham, C. P., Pavlakis, G. N. & Felber, B., K. (1994). Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J. Virol. 68, 2986-2993.
56. Ohme-Takagi, M., Taylor, C. B., Newman, T. C. & Green, P. J. (1993). The effect of sequences with high AU content on mRNA stability in tobacco. Proc. Natl Acad. Sci. USA, 90, 11811-11815.
57. Olsen, H. S., Cochrane, A. W., Dillon, P. J., Nalin, C. M. & Rosen, C. A. (1990a). Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev. 4, 1357-1364.
58. Olsen, H. S., Nelbrock, P., Cohrane, A. W. & Rosen, C. A. (1990b). Secondary structure is the major determinant for interaction of HIV Rev protein with RNA. Science, 247, 845-848.
59. O'Reilly M. M., McNally M. T. & Beemon, K. L. (1995). Two strong 5′ splice sites and competing suboptimal 3′ splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA. Virology, 213, 373-385.
60. Reddy T. R., Kraus, G., Suhasini, M., Leavitt, M. C. & Wong-Staal, F. (1995). Indentification and mapping of inhibitory sequences in the human immunodeficiency virus type 2 vif gene. J. Virol. 69, 5167-5170.
61. Richard, N., Iacampo, S. & Cochrane, A. (1994). HIV-1 Rev is capable of shuttling between the nucleus and the cytoplasm. Virology, 204, 123-131.
62. Robert-Guroff, M., Popovic, M., Gartner, S., Markham, P., Gallo, R. C. & Reitz, M. S. (1990). Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Virol. 64, 3391-3398.
63. Rosen, C. A., Terwilliger, E., Dayton, A. I., Sodrowski, J. G. & Haseltine, W. A. (1988). Intragenic cis-acting art-responsive sequences of the human immunodeficiency virus. Proc. Natl Acad. Sci. USA, 85, 2071-2075.
64. Schwartz, S., Felber, B. K., Benko, D. M., Fenyo, E.-M. & Pavlakis, G. N. (1990a). Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1. J. Virol. 64, 2519-2529.
65. Schwartz, S., Felber, B. K., Fenyo, E.-M. & Pavlakis, G. N. (1990b). Env and Vpu proteins of human immuno-deficiency virus type 1 are produced from multiple bicistronic mRNAs. J. Virol. 64, 5448-5456.
66. Schwartz, S., Campbell, M., Nasioulas, G., Harrison, J., Felber, B. K. & Pavlakis, G. N. (1992a). Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Revindependent gag expression. J. Virol. 66, 7176-7182.
67. Schwartz, S., Felber, B. K. & Pavlakis, G. N. (1992b). Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66, 150-159.
68. Shaw, G. & Kamen, R. (1986). A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell, 46, 659-667.
69. Sodroski, J., Goh, W. C., Rosen, C. A., Dayton, A., Terwilliger, E. & Haseltine, W. A. (1986). A second post-transcriptional activator gene required for HTLV-III replication. Nature, 321, 412-417.
70. Staffa, A. & Cochrane, A. (1994). The tat-rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3′ splice site. J. Virol. 68, 3071-3079.
71. Staffa, A. & Cochrane, A. (1995). Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1. Mol. Cell Biol. 15, 4597-4605.
72. Stutz, F. & Rosbash, M. (1994). A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation. EMBO J. 13, 4096-4104.
73. Stutz, F., Neville, M. & Rosbach, M. (1995). Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 Rev protein in yeast. Cell, 82, 495-506.
74. Tiley, L. S., Malim, M. H., Tewary, H. K., Stockley P. G. & Cullen, B. R. (1992). Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc. Natl Acad. Sci. USA, 89, 758-762.
75. Vakalopoulou, E., Schaack, J. & Shenk, T. (1991). A 32-kilodalton protein binds to AU-rich domains in the 3′ untranslated regions of rapidly degraded mRNAs. Mol. Cell Biol. 11, 3355-3364.
76. Wen, W., Meinkoth, J. L., Tsien, R. Y. & Taylor, S. S. (1995). Identification of a signal for rapid export of proteins from the nucleus. Cell, 82, 463-473.
77. Wolff, B., Cohen, G., Hauber, J., Meshcheryakova, D. & Rabeck, C. (1995). Nucleocytoplasmic transport of the Rev protein of human immunodeficiency virus type 2 is dependent on the activation domain of the protein. Exp. Cell Res. 217, 31-41.
78. Zahler, A. M., Neugelauer, K. M., Lane, W. S. & Roth, M. B. (1993). Distinct functions of SR proteins in alternative pre-mRNA splicing. Science, 260, 219-221.
79. Zapp, M. L. & Green, M. R. (1989). Sequence-specific binding by the HIV-1 Rev protein. Nature, 342, 714-716.
80. Zapp, M. L., Hope, T. J., Parslow, T. G. & Green, M. R. (1991). Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc. Natl Acad. Sci. USA, 88, 7734-7738.
81. Zemmel, R. W., Kelley A. C., Karn, J., Butler, P. J. G. (1996). Flexible regions of RNA structure facilitate co-operative Rev assembly on the Rev-response element. J. Mol. Biol. in press.
82. Zolotukhin, A. S., Valentin, A., Pavlakis, G. N. & Felber, B. K. (1994). Continuous propogation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol. 68, 7944-7952.